Authors:
Gronvall-Nordquist, JLE
Backlund, LB
Garpenstrand, L
Ekblom, J
Landin, B
Yu, PH
Oreland, L
Rosenqvist, U
Citation: Jle. Gronvall-nordquist et al., Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus, J DIABET C, 15(5), 2001, pp. 250-256
Authors:
Garpenstrand, H
Annas, P
Ekblom, J
Oreland, L
Fredrikson, M
Citation: H. Garpenstrand et al., Human fear conditioning is related to dopaminergic and serotonergic biological markers, BEHAV NEURO, 115(2), 2001, pp. 358-364
Authors:
Damberg, M
Eller, M
Tonissaar, M
Oreland, L
Harro, J
Citation: M. Damberg et al., Levels of transcription factors AP-2 alpha and AP-2 beta in the brainstem are correlated to monoamine turnover in the rat forebrain, NEUROSCI L, 313(1-2), 2001, pp. 102-104
Authors:
Harro, M
Eensoo, D
Kiive, E
Merenakk, L
Alep, J
Oreland, L
Harro, J
Citation: M. Harro et al., Platelet monoamine oxidase in healthy 9-and 15-years old children: The effect of gender, smoking and puberty, PROG NEUR-P, 25(8), 2001, pp. 1497-1511
Authors:
Obata, T
Yamanaka, Y
Kinemuchi, H
Oreland, L
Citation: T. Obata et al., Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP+) into the striatum is associated with hydroxyl free radical generation, BRAIN RES, 906(1-2), 2001, pp. 170-175
Authors:
Sakurai, E
Sakurai, E
Tanaka, Y
Watanabe, T
Jossan, SS
Oreland, L
Citation: E. Sakurai et al., Effects of histamine H3-receptor ligands on brain monoamine oxidase in various mammalian species, BRAIN RES, 906(1-2), 2001, pp. 180-183
Authors:
Harro, J
Tonissaar, M
Eller, M
Kask, A
Oreland, L
Citation: J. Harro et al., Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry, BRAIN RES, 899(1-2), 2001, pp. 227-239
Authors:
Kinemuchi, H
Kobayashi, N
Takahashi, K
Takayanagi, K
Arai, Y
Tadano, T
Kisara, K
Oreland, L
Citation: H. Kinemuchi et al., Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine, ARCH BIOCH, 385(1), 2001, pp. 154-161
Authors:
Damberg, M
Garpenstrand, H
Alfredsson, J
Ekblom, J
Forslund, K
Rylander, G
Oreland, L
Citation: M. Damberg et al., A polymorphic region in the human transcription factor AP-2 beta gene is associated with specific personality traits, MOL PSYCHI, 5(2), 2000, pp. 220-224
Authors:
Harro, J
Merikula, A
Lepiku, M
Modiri, AR
Rinken, A
Oreland, L
Citation: J. Harro et al., Lesioning of Locus coeruleus projections by DSP-4 neurotoxin treatment: Effect on amphetamine-induced hyperlocomotion and dopamine D-2 receptor binding in rats, PHARM TOX, 86(5), 2000, pp. 197-202
Authors:
Prince, JA
Harro, J
Blennow, K
Gottfries, CG
Oreland, L
Citation: Ja. Prince et al., Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics, NEUROPSYCH, 22(3), 2000, pp. 284-292
Authors:
Damberg, M
Garpenstrand, H
Berggard, C
Asberg, M
Hallman, J
Oreland, L
Citation: M. Damberg et al., The genotype of human transcription factor AP-2 beta is associated with platelet monoamine oxidase B activity, NEUROSCI L, 291(3), 2000, pp. 204-206
Citation: A. Kask et al., Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat, NEUROPEPTID, 34(1), 2000, pp. 58-61
Citation: M. Damberg et al., Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2, LIFE SCI, 68(6), 2000, pp. 669-678
Authors:
Yassin, MS
Ekblom, J
Xilinas, M
Gottfries, CG
Oreland, L
Citation: Ms. Yassin et al., Changes in uptake of vitamin B-12 and trace metals in brains of mice treated with clioquinol, J NEUR SCI, 173(1), 2000, pp. 40-44
Authors:
Jonsson, EG
Norton, N
Gustavsson, JF
Oreland, L
Owen, MJ
Sedvall, GC
Citation: Eg. Jonsson et al., A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers, J PSYCH RES, 34(3), 2000, pp. 239-244
Authors:
Kinemuchi, H
Jinbo, M
Tabata, A
Toyoshima, Y
Arai, Y
Tadano, T
Kisara, K
Oreland, L
Citation: H. Kinemuchi et al., 2-Bromoethylamine, a suicide inhibitor of tissue-bound semicarbazide-sensitive amine oxidase, JPN J PHARM, 83(2), 2000, pp. 164-166
Authors:
Harro, J
Haidkind, R
Harro, M
Modiri, AR
Gillberg, PG
Pahkla, R
Matto, V
Oreland, L
Citation: J. Harro et al., Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment, EUR NEUROPS, 10(1), 1999, pp. 5-16
Authors:
Prince, JA
Blennow, K
Gottfries, CG
Karlsson, I
Oreland, L
Citation: Ja. Prince et al., Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics, NEUROPSYCH, 21(3), 1999, pp. 372-379
Authors:
Garpenstrand, H
Ekblom, J
Backlund, LB
Oreland, L
Rosenqvist, U
Citation: H. Garpenstrand et al., Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy, DIABET MED, 16(6), 1999, pp. 514-521
Authors:
Harro, J
Pahkla, R
Modiri, AR
Harro, M
Kask, A
Oreland, L
Citation: J. Harro et al., Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and beta-adrenoceptor binding in the rat, J NEURAL TR, 106(7-8), 1999, pp. 619-629
Authors:
Ekblom, J
Gronvall, J
Lennernast, B
Nilsson, S
Garpenstrand, H
Oreland, L
Citation: J. Ekblom et al., Elevated activity of semicarbazide-sensitive amine oxidase in blood from patients with skeletal metastases of prostate cancer, CLIN SCI, 97(1), 1999, pp. 111-115